1 Min Read
June 1 (Reuters) - Johnson & Johnson:
* Janssen Sciences Ireland UC -VIIV Healthcare made regulatory submissions to EMA,FDA for dolutegravir and rilpivirine Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.